Bio Schutz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.70 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth 42.23%
- Profit Growth 16.22%
- Ebitda 404.72%
- Net Worth 85.36%
- Total Assets 14.21%
About Bio Schutz Pharmaceuticals
Bio Schutz Pharmaceuticals Private Limited (BSPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 2015 (Nine years and seven months 17 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.00 M.
Kanakamma Kochukutty, Ratheeshkumar Vijayan, and Renjith Muttathparambil serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74990KL2015PTC038664
-
Company No.
038664
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jun 2015
-
Date of AGM
26 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Bio Schutz Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratheeshkumar Vijayan
|
Managing Director | 17-Jun-2015 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kanakamma Kochukutty
|
Director | 17-Jun-2015 | Current |
|
Renjith Muttathparambil
|
Director | 17-Jun-2015 | Current |
Financial Performance of Bio Schutz Pharmaceuticals.
Bio Schutz Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.23% increase. The company also saw a substantial improvement in profitability, with a 16.22% increase in profit. The company's net worth Soared by an impressive increase of 85.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Schutz Pharmaceuticals?
In 2019, Bio Schutz Pharmaceuticals had a promoter holding of 14.29% and a public holding of 85.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2017 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Bio Schutz Pharmaceuticals?
Unlock and access historical data on people associated with Bio Schutz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Schutz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Schutz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.